A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
 
Sponsors and Collaborators
Sarcoma Alliance for Research through Collaboration
AstraZeneca
 
Contacts
Denise Reinke,MS,NP,President
734-930-7600
 
Ann Johnson, RN, CCRC
734-930-7600
 
Investigator
Kristin Baird, MD
National Cancer Institute-Pediatric Oncology Branch
 
 
ClinicalTrials.gov Identifier